DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Methyl beta-galactoside is an investigational drug.
There have been 16 clinical trials for Methyl beta-galactoside. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2011.
The most common disease conditions in clinical trials are Cardiovascular Diseases, Anemia, Sickle Cell, and Aphasia, Primary Progressive. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI), and Children's Mercy Hospital Kansas City.
There are sixty-seven US patents protecting this investigational drug and five hundred and fifty-five international patents.
Recent Clinical Trials for Methyl beta-galactoside
|Prolotherapy Versus Cortisone Injections for Partial Rotator Cuff Tears||Hadassah Medical Organization||Phase 2|
|Treatment of Renal Stones With Frankincense (Luban)||Sultan Qaboos University||Phase 1/Phase 2|
|Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation||Ghada Mohammed AboelFadl||Phase 2/Phase 3|
Top disease conditions for Methyl beta-galactoside
Top clinical trial sponsors for Methyl beta-galactoside
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Methyl beta-galactoside||Start Trial||Multifunctional (meth)acrylate manufacturing method||TOAGOSEI CO., LTD. (Tokyo, JP)||Start Trial|
|Methyl beta-galactoside||Start Trial||Method for producing (meth)acrylate||TOAGOSEI CO., LTD (Tokyo, JP)||Start Trial|
|Methyl beta-galactoside||Start Trial||Self-repairing polyurethane networks||Clemson University (Clemson, SC)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Methyl beta-galactoside||China||106029628||2034-04-16||Start Trial|
|Methyl beta-galactoside||European Patent Office||3133058||2034-04-16||Start Trial|
|Methyl beta-galactoside||Japan||6273539||2034-04-16||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|